ONCOmmunity

Found 15774 articles

Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin

MUC5AC as a specific mucin species to which PAM4 is reactive. »
11/20/13

High mitochondria content is associated with prostate cancer disease progression

Study evaluates prognostic value of MTC02, a marker for mitochondrial content, in prostate cancer. »
11/21/13

Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls

Specific MMP-generated collagen fragments differentiate PC patients from healthy controls when measured in serum. »
11/21/13

Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study

Novel functional polymorphisms of the UGT2B17 and UGT2B15 genes evaluated in epidemiologic studies. »
11/22/13

Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β

Efficacy of boldine in apoptosis-induced in T24 cells is correlated with modulation of AKT. »
03/06/12

Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.

Higher circulating IGF-I levels may increase risk specifically of receptor-positive, but not receptor-negative, breast cancer. »
06/18/13

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.

Low-dose tamoxifen or fenretinide exhibits favorable hormonal profiles as single agents for breast cancer. »
09/17/13

Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.

High HOTAIR expression in primary tumors is significantly associated with worse prognosis. »
07/01/13

Low-dose Aspirin Use After Diagnosis of Colorectal Cancer Does not Increase Survival: a Case-Control Analysis of a Population-Based Cohort.

Low-dose aspirin usage after diagnosis of colorectal cancer did not increase survival time. »
07/10/13

Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.

Chromodomain helicase DNA binding protein 5 (CHD5) is a family member of chromatin remodeling factors. The epigenetic silencing mechanisms of CHD5 in colorectal cancer have not been well studied. »
04/23/13

< Prev Next >